Squawk on the Street podcast

Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24

0:00
3:37
Recuar 15 segundos
Avançar 15 segundos

Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

Mais episódios de "Squawk on the Street"